Hollings researchers will develop AI-driven tools to better match cancer patients to marketed therapies and clinical trials.

The use of active surveillance in patients with intermediate-risk prostate cancer has increased in recent years, according to research published in JAMA Network Open. Researchers analyzed data from ...

Breast and prostate cancer might have more awareness campaigns ... The diameter of a mole that is larger than the size of a ...

Prostate cancer is one of the most common cancers in men ... uproar Woman reveals these 4 exercises helped get rid of her ...

All the time in the world is never enough time. You especially notice this when you don't know if you'll get another day.

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.

PET imaging using a radiolabeled antibody picked up clear cell renal cell carcinoma and could help avert unnecessary biopsies ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, ...

BRCA mutations are inextricably linked with breasts, but they can also lead to cancer in the pancreas, the prostate, and ...

Researchers have identified a new role for the enzyme EZH2 in promoting the progression of aggressive, treatment-resistant ...

Hirst III Professors of Oncology in Pathology and members of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. The scientists found that the absence of a protein called PKCλ/ι in ...